ActionPPE

The record of the pandemic PPE mobilization, and a working reference for the practices that lived it.

The Record

Where the pandemic PPE purchasing programs went — and how practices source PPE in 2026

Reviewed August 2026First published.

Every channel built to get PPE to independent practices during the shortage is now gone. The medical-society group buys — including the one that operated at this web address — stopped adding products in mid-2021. Get Us PPE, the donation clearinghouse, stopped fundraising that July. Project N95, the nonprofit marketplace that outlasted them all, closed its shop in December 2023 after moving more than 37 million units. A practice manager who bookmarked any of those links in 2021 now finds a dead page — and the question that sent doctors to those channels in the first place, who can be trusted to sell authentic PPE, did not close with them. This article records where each channel went, and where its function lives now.

Flat archival branching diagram: four 2020 emergency PPE channels — donation box, broker envelope, medical society, freight crate — converge through a narrow 2021 pinch marked with a brass tick, then re-emerge as three orderly 2026 channels ending in a distributor warehouse, a group-purchasing ledger, and an oxblood verification checkmark
The emergency channels of 2020–2021 and where each one's function moved by 2026.

The emergency channels of 2020–2021

The ad-hoc purchasing programs existed because the normal channel failed selectively. When demand spiked in the spring of 2020 — a Premier survey of nearly 1,600 hospitals that April found they needed roughly seventeen times their usual N95 supply — the large medical distributors put products on allocation and served their biggest contracts first. Supply Chain Dive's February 2021 reporting on what it called the "haves and have nots" documented the result: Trinity Health was holding 120 days of stock for most items and Indiana University Health a six-month reserve, while requests to the donation clearinghouse Get Us PPE surged 260 percent between November and December 2020, and 86 percent of the facilities reporting N95 shortages to it in January 2021 reported unsafe usage rates. The same reporting put peak spot-market N95 prices around $7 per respirator, against pre-pandemic costs of 11 to 38 cents.

Independent practices — too small for allocation priority, too exposed to shut down — got their PPE through four improvised channels:

It is worth recording why medical societies, of all institutions, ended up running storefronts. They held the two assets the emergency actually demanded: a membership list that reached exactly the practices the distributors were skipping, and standing trust with those practices at the precise moment CDC was estimating that a majority of one whole product category on the open market was counterfeit. The checkout pages captured from the program at this address asked buyers to name the participating organization to credit for their purchase — a dropdown listing more than two dozen societies — because the model's whole engine was affiliation. A cold website selling KN95s in 2020 was indistinguishable from a counterfeiter; a county medical society emailing its own members was not. That trust asset is also why the model could not outlive the emergency: a society lends its name against a crisis, not as a permanent retail brand.

The mid-2021 freeze

None of the society programs published a shutdown notice. What the archival record shows instead is a freeze: as vaccination replaced barrier protection as the urgent clinical task in mid-2021, the programs simply stopped moving. Dated Wayback Machine captures of the program at this address trace the pattern, and it is representative of the model:

The freeze had a plain economic logic. The group buys existed to concentrate scattered small orders into volumes a factory would prioritize during a shortage. Once distributors came off allocation and prices fell back toward normal, a society storefront charging near-market prices for the same products a distributor now stocked had no function left — and no one needed to announce that for it to be true.

Project N95, the last intermediary

Project N95 outlived the society programs by two and a half years, because its product was never really aggregation — it was trust. The organization ran what The Sick Times' December 2023 report called an extensive vetting process on the masks it sold, and, in that report's words, "became a trusted source." Its own wind-down notice states the totals: more than 37 million units of PPE distributed through its shop, and more than 5 million items donated to frontline and essential workers.

The end came on the revenue side. The organization's November 20, 2023 announcement cited "a precipitous drop off of sales of masks and dwindling donations"; its wind-down page states that shop proceeds and donor contributions were no longer sufficient to support the charitable mission. The shop stopped selling in mid-December 2023 — the announcement set December 15 as the last purchase day, The Sick Times reported December 17, and the University of Nebraska Medical Center's Transmission newsletter (December 5, 2023) reported December 18 — with hardship requests accepted through December 20. The UNMC piece ran under the headline "Two N95 Companies Shut Down, as an Era Ends," which is the accurate summary: Project N95 was the last general-purpose intermediary whose whole job was standing between healthcare buyers and counterfeit PPE. What remained after the closure, per the wind-down page, was a static guide pointing to previously vetted products at third-party retailers.

The instructive detail for 2026 is why it failed: not scandal, not supply, but the same demand collapse that froze the society programs in 2021, arriving on a delay. When buyers stopped feeling at risk, they stopped paying the small premium that independent vetting cost — and the vetting infrastructure dissolved.

What happened to the domestic manufacturers

The purchasing programs' disappearance was half of the story; the supply side ran the same arc. The federal government invested over $1 billion in 2020 to build domestic PPE manufacturing, and dozens of American mask and glove startups launched into the shortage. Healthcare Brew's August 2025 retrospective found that those companies have mostly shut down, undercut on price as imports rebounded; the American Medical Manufacturers Association's executive director, quoted in that reporting, put it plainly — many of the companies that stood up during Covid disappeared because they were "just undercut overnight." The American Hospital Association calculated that the U.S. imported over $75 billion in medical devices and supplies in 2024 alone, and hospital purchasing has broadly returned to cost-driven, just-in-time models rather than pandemic-era stockpiling.

For a small practice the practical consequence is that the 2026 supply chain looks structurally like the 2019 one: import-dependent, price-optimized, and thin. The channels that improvised around its failure were not replaced with sturdier ones; they were dismantled when the emergency ended. What a practice controls is its own reserve — the arithmetic of which is covered in the stock-planning article of The Reference.

How a practice sources PPE in 2026

Each emergency channel's function still exists — it just moved. The table maps where.

Where each 2020–2021 emergency channel's function lives in 2026 (as of August 2026).
2020–2021 channel What it actually provided Where that function lives in 2026
Medical-society group buys Order aggregation for volume pricing and factory priority Group purchasing organizations (GPOs) and society-endorsed supply programs; standard distributor accounts, now off allocation
Project N95's vetting Authenticity checking between buyer and seller Self-verification: the TC number checked against the NIOSH Certified Equipment List, markings checked against NIOSH publication 2025-105
Get Us PPE's clearinghouse Emergency allocation when purchasing failed No general replacement; state stockpile programs vary — a practice's own reserve is the dependable layer
Spot-market brokers Volume at any price, authenticity unverified Still exists on third-party marketplaces; NIOSH guidance recommends authorized distributors instead

Two of those rows deserve a plainer translation. First, the group-purchasing function: a GPO negotiates contract pricing with distributors and manufacturers on behalf of its members, which is what the society storefronts were improvising by hand in 2020. Many state medical and dental associations now route members to an endorsed GPO or purchasing partner instead of operating anything themselves — the affiliation survives, the storefront does not. A small practice that wants 2020's volume pricing without 2020's improvisation joins one through its association or its distributor, and the ordinary distributor account does the rest, because nothing is on allocation in a normal year.

Second, the reserve function. New York and California now require their hospitals to hold PPE reserves — built on 60- and 90-day constructs respectively — but no federal or state rule sets an equivalent for medical and dental offices, a gap the stock-planning article works through with CDC's burn-rate calculator. The practical point for sourcing is timing: the practice that buys on a schedule, rotating stock ahead of its shelf life (what the expiration date means), never has to buy in the market conditions this article's first section describes.

The vetting that Project N95 performed as a service is now a workflow any practice can run itself, because the primary tools are public:

Guidance in flux — checked August 2026

The 2025 restructuring of federal health agencies reached NIOSH itself: positions supporting the Respirator Approval Program were cut in early 2025 and subsequently reinstated, and a proposal to fold NIOSH into a new National Center for Chemicals and Toxins remains pending for FY2027. Through all of it the approval program has continued operating and the Certified Equipment List has remained live; a dated status section is maintained in the verification guide.

What this record can and cannot say

The account of the society-model wind-down rests on dated Wayback Machine captures, and captures are samples, not surveillance: a page's last capture bounds when it changed, not exactly when. No formal shutdown notice from the program formerly at this address — or from most of its peer programs — has been found in the archival record, so the freeze chronology above is an inference from what stopped appearing, stated as such. Project N95's closure, by contrast, is documented in its own words. On the 2026 side, the sourcing workflow above describes verification mechanics, not medical selection: which respirator a given practice needs for a given exposure is a respiratory-protection-program question under 29 CFR 1910.134, covered in the small-practice OSHA article, and contemporaneous sources disagree by a few days on Project N95's exact final sales date, as noted above.

Primary sources

The modern version of this article's question — is the box my distributor sent genuine? — is answered step by step in How to verify a respirator is really NIOSH-approved. How the group buys themselves worked is recorded in the N95 group-buy article, and the full history of the program formerly at this address in What was ActionPPE?. The registry of participating societies is at the partner-societies page.